Inogen (INGN) sees Significant Insider Selling Continuing

Thursday, October 12, 2017 10:15 PM ET

Inogen (INGN) sees Significant Insider Selling Continuing

There was a notable sale of shares of Inogen by an insider today, as indicated in a form 4 document filed with the SEC. One insider — Alison Bauerlein, Officer — sold 15,000 shares in the company having a market value of approximately $1,423,954. There was one insider buy/sell transaction in the past 90 days prior to this transaction which resulted in the sale of 6,667 shares. Adding the most recent activity to this 90-day history indicates insider trades have been net sales of 21,667 shares and have averaged 10,834 shares per transaction over this time period.

The number of insider buy/sell trades at Inogen is higher than that of the 81 peer company average over the last 90-day period. The Medical Equipment, Supplies & Distribution peer group saw 89 buy/sell trades during this period for an average of 1.1 transactions per company. However, the number of shares traded per transaction by Inogen insiders is lower than its peers. Within the peer group there were 394,951 shares purchased and 1,195,570 shares sold with company insiders having sold 8,996 shares on average over this time period.

Insider buying and selling activity that is significant has been determined by eliminating all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers in evaluating and writing this story.

Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.

For more information, contact UpTick at Copyright 2017 UpTick Data Technologies. All rights reserved.

This entry was posted in InsiderNews and tagged , , , , . Bookmark the permalink.